AvalonBay Communities Free cash flow increased by 11.5% to $359.48M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.2%, from $367.53M to $359.48M. Over 4 years (FY 2021 to FY 2025), Free cash flow shows an upward trend with a 7.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $209.35M | $294.65M | $254.36M | $314.21M | $261.48M | $386.94M | $298.99M | $364.84M | $304.00M | $423.37M | $289.52M | $375.42M | $332.98M | $434.24M | $271.90M | $367.53M | $317.14M | $402.19M | $322.47M | $359.48M |
| QoQ Change | — | +40.7% | -13.7% | +23.5% | -16.8% | +48.0% | -22.7% | +22.0% | -16.7% | +39.3% | -31.6% | +29.7% | -11.3% | +30.4% | -37.4% | +35.2% | -13.7% | +26.8% | -19.8% | +11.5% |
| YoY Change | — | — | — | — | +24.9% | +31.3% | +17.5% | +16.1% | +16.3% | +9.4% | -3.2% | +2.9% | +9.5% | +2.6% | -6.1% | -2.1% | -4.8% | -7.4% | +18.6% | -2.2% |